NCT06518343View on ClinicalTrials.gov

Trimethylamine N-oxide Effects of a Pomegranate Supplement Simultaneously With Carnitine (TESSA)

NAActive, not recruitingINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

August 12, 2024

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2027

Conditions
Healthy
Interventions
DIETARY_SUPPLEMENT

L-carnitine + Pomegranate extract

Participants will consume 1.5 grams L-carnitine with 1.6 grams pomegranate extract at one visit during one intervention period

DIETARY_SUPPLEMENT

L-carnitine + Microcrystalline cellulose

Participants will consume 1.5 grams L-carnitine with 1.5 grams microcrystalline cellulose at one visit during one intervention period

Trial Locations (1)

NR4 7UQ

Quadram Institute, Norwich

All Listed Sponsors
collaborator

Norfolk and Norwich University Hospitals NHS Foundation Trust

OTHER

collaborator

Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK)

OTHER

lead

Quadram Institute Bioscience

OTHER

NCT06518343 - Trimethylamine N-oxide Effects of a Pomegranate Supplement Simultaneously With Carnitine (TESSA) | Biotech Hunter | Biotech Hunter